Loading...
XSHE
300636
Market cap477mUSD
Dec 05, Last price  
8.04CNY
1D
0.00%
1Q
-13.36%
IPO
34.70%
Name

Jiangxi Synergy Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:300636 chart
P/E
31.68
P/S
4.45
EPS
0.25
Div Yield, %
0.50%
Shrs. gr., 5y
6.15%
Rev. gr., 5y
12.94%
Revenues
759m
+5.09%
104,615,908141,555,599212,574,224274,814,061250,078,505296,716,027267,124,046413,058,080435,420,102592,126,648719,908,426722,138,705758,890,499
Net income
107m
+0.57%
8,028,34616,883,60439,208,36562,879,09457,996,31565,457,72624,530,81648,309,30870,051,14981,119,813100,667,359105,983,257106,584,102
CFO
285m
+74.16%
014,417,07264,501,99079,422,48260,445,42134,053,90474,932,539080,066,182131,338,816195,996,737163,748,533285,189,694
Dividend
Jun 21, 20240.04 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jiangxi Synergy Pharmaceutical Co., Ltd. manufactures and sells APIs worldwide. It offers APIs, liquid crystal compounds, and intermediates. Jiangxi Synergy Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Yichun, the People's Republic of China.
IPO date
Mar 31, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT